Fabian Gusovsky holds a diploma in pharmacy and biochemistry from the University of Buenos Aires, and a PhD in Pharmacology from Rush University in Chicago, IL. He worked at the US National Institutes of Health, at the Laboratory of Bioorganic Chemistry, NIDDK until 1992. He then joined Eisai Inc, in Andover, MA as a Senior Scientist and was Therapeutic Area Head in Immunology and Atopic diseases by 2007. He is currently Head of Global Health Research where he manages a portfolio of projects directed at finding solutions for Tropical Diseases and Public Health. He is a member of Eisai’s Access to Medicines Team, and Manager for the Americas for the Diethylcarbamazine (a drug used for the treatment of lymphatic filariasis) donation program. He is a member of the Executive Group of the Global Alliance for the Elimination of Lymphatic Filariasis, and of the Executive Council supporting the Gates Foundation CEO Round Table.